Price target
53.340.00 0.00%
The 22 analysts offering 1 year price forecasts for BMY have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to BMY in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BMY EPS for the last quarter is −4.40 USD despite the estimation of −4.41 USD. In the next quarter EPS is expected to reach 1.68 USD. Track more of Bristol-Myers Squibb Company financials and stay on top of what is up with the company.
In the next quarter Bristol-Myers Squibb Company revenue is expected to reach 11.51 B USD. Check out Bristol-Myers Squibb Company revenue and earnings and make informed decisions.
According to analysts, BMY price target is 53.34 USD with a max estimate of 75.00 USD and a min estimate of 37.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with BMY news and stock market news.
We've gathered opinions of 28 analysts rating BMY stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.